Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

The inflammatory caspases in colitis and sepsis

EF 2008-09

Résumé
Inflammatory disorders, whether they are chronic or acute affect a large number of North Americans. Crohn's disease, a periodic and lifelong inflammatory disorder of the digestive, affects between 400,000 and 600,000 people in North America, while sepsis constitutes both the number one cause of death in Intensive Care Units and 10th cause of death overall worldwide. These conditions occur when the immune system contributes to damage to tissues causing inflammation, which can lead to several mechanical and life-threatening complications. Chronic inflammatory disorders have also been linked to increased risk of cancer, notably individuals diagnosed with Crohns colitis are up to 5 times as likely to develop colon cancer during their lifetime. Although much remains to be discovered with regards to the etiology of these diseases, it has been shown that a family of proteins, the inflammatory caspases, plays major roles in the intricate cellular mechanisms involved. The aims of this research is to further explore the various activities of these caspases in inflammatory disorders in order to better understand their functions and potentially identify novel therapeutic targets. The results of this study will benefit patients, clinicians and researchers by providing important data with respect to the cellular mechanisms involved, and yield knowledge which may lead to the development of novel therapeutics strategies.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184441
Name
Leblanc Philippe M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The inflammatory caspases in colitis and sepsis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bacterial Infections; Cell Signaling Pathways; Crohn'S Disease; Hmgb1; Inflammation; Inflammatory Caspases; Intensive Care; Mouse And Human Colitis Models; Quality Of Life; Sepsis
Abstract
Inflammatory disorders, whether they are chronic or acute affect a large number of North Americans. Crohn's disease, a periodic and lifelong inflammatory disorder of the digestive, affects between 400,000 and 600,000 people in North America, while sepsis constitutes both the number one cause of death in Intensive Care Units and 10th cause of death overall worldwide. These conditions occur when the immune system contributes to damage to tissues causing inflammation, which can lead to several mechanical and life-threatening complications. Chronic inflammatory disorders have also been linked to increased risk of cancer, notably individuals diagnosed with Crohns colitis are up to 5 times as likely to develop colon cancer during their lifetime. Although much remains to be discovered with regards to the etiology of these diseases, it has been shown that a family of proteins, the inflammatory caspases, plays major roles in the intricate cellular mechanisms involved. The aims of this research is to further explore the various activities of these caspases in inflammatory disorders in order to better understand their functions and potentially identify novel therapeutic targets. The results of this study will benefit patients, clinicians and researchers by providing important data with respect to the cellular mechanisms involved, and yield knowledge which may lead to the development of novel therapeutics strategies.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Leblanc, Philippe M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~